Utility of circulating tumor DNA in esophageal cancer: A potential prognostic biomarker in tumor staging, monitoring of treatment response and detection of recurrent disease.

被引：0
|
作者：
Cabalag, Carlos Suhady [1 ]
Yates, Michael [1 ]
Corrales, Mariana B. [1 ]
Yeh, Paul [1 ]
Wong, Stephen Q. [1 ]
Zhang, Bonnie [1 ]
Fujihara, Kenji M. [1 ]
Chong, Lynn [2 ]
Hii, Michael [2 ]
Dawson, Sarah-Jane [1 ]
Phillips, Wayne A.
Duong, Cuong P. [1 ]
Clemons, Nicholas J. [1 ]
机构：
[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[2] St Vincents Hosp Melbourne, Melbourne, Vic, Australia
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
539
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer
    Reeh, Matthias
    Effenberger, Katharina E.
    Koenig, Alexandra M.
    Riethdorf, Sabine
    Eichstaedt, Dominique
    Vettorazzi, Eik
    Uzunoglu, Faik G.
    Vashist, Yogesh K.
    Izbicki, Jakob R.
    Pantel, Klaus
    Bockhorn, Maximilian
    ANNALS OF SURGERY, 2015, 261 (06) : 1124 - 1130
  • [2] Detection of Circulating Tumor DNA in Plasma: A Potential Biomarker for Esophageal Adenocarcinoma
    Egyud, Matthew
    Tejani, Mohamedtaki
    Pennathur, Arjun
    Luketich, James
    Sridhar, Praveen
    Yamada, Emiko
    Stahlberg, Anders
    Filges, Stefan
    Krzyzanowski, Paul
    Jackson, Jennifer
    Kalatskaya, Irina
    Jiao, Wei
    Nielsen, Gradon
    Zhou, Zhongren
    Litle, Virginia
    Stein, Lincoln
    Godfrey, Tony
    ANNALS OF THORACIC SURGERY, 2019, 108 (02): : 343 - 349
  • [3] Circulating tumor cells as a biomarker for monitoring: Disease progression, treatment response, and minimal residual disease.
    Raut, Nirmal Vivek
    Bharde, Atul
    Gourishankar, Aland
    Jayant, Sreeja
    Garbhe, Meghana
    Gosavi, Sayali
    Janorkar, Apoorva
    D'Souza, Alain
    Vasudevan, Aravindan
    Khandare, Jayant
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Liquid Biopsies for Monitoring Medulloblastoma: Circulating Tumor DNA as a Biomarker for Disease Progression and Treatment Response
    Buccilli, Barbara
    Molina, Maria A. Rodriguez
    Palomeque, Daniela P. Redrovan
    Saban, Cindy A. Herrera
    Caliwag, Fides M. C.
    Flores, Cristian Jenifer S. Contreras
    Abeysiriwardana, Chamathi W. J.
    Diarte, Edna
    Arruarana, Victor S.
    Martinez, Ernesto Calderon
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [5] Utility of Circulating Tumor DNA for Detection and Monitoring of Endometrial Cancer Recurrence and Progression
    Moss, Esther L.
    Gorsia, Diviya N.
    Collins, Anna
    Sandhu, Pavandeep
    Foreman, Nalini
    Gore, Anupama
    Wood, Joey
    Kent, Christopher
    Silcock, Lee
    Guttery, David S.
    CANCERS, 2020, 12 (08) : 1 - 13
  • [6] The Potential Clinical Utility of Circulating Tumor DNA in Esophageal Adenocarcinoma: From Early Detection to Therapy
    Kosovec, Juliann E.
    Zaidi, Ali H.
    Pounardjian, Tamar S.
    Jobe, Blair A.
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [7] Early Circulating Tumor DNA Kinetics as a Dynamic Biomarker of Cancer Treatment Response
    Li, Aaron
    Lou, Emil
    Leder, Kevin
    Foo, Jasmine
    JCO CLINICAL CANCER INFORMATICS, 2025, 9
  • [8] A Review of Circulating Tumor DNA in the Diagnosis and Monitoring of Esophageal Cancer
    Min, Jiang
    Zhou, Huilin
    Jiang, Su
    Yu, Hong
    MEDICAL SCIENCE MONITOR, 2022, 28
  • [9] The Utility of Circulating Tumor Cells in Monitoring Patients with Recurrent Ovarian Cancer
    Kindelberger, D. W.
    Matulonis, U.
    MODERN PATHOLOGY, 2010, 23 : 250A - 250A
  • [10] The Utility of Circulating Tumor Cells in Monitoring Patients with Recurrent Ovarian Cancer
    Kindelberger, D. W.
    Matulonis, U.
    LABORATORY INVESTIGATION, 2010, 90 : 250A - 250A
12345